Video

Aerie COO: Expanding innovation of glaucoma therapeutics

Author(s):

OT Staff Reports
Conferences|GLAUCOMA 360

Tom Mitro, president, COO of Aerie Pharmaceuticals, discusses the key highlights from an industry panel discussion titled "Innovate without borders," held during the Glaucoma 360 New Horizons Forum, including the company's role in expanding into the global glaucoma therapeutics market.

See more Glaucoma 360 coverage

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
AAO 2024: Weijie Violet Lin, MD, discusses risk factors for epithelium-off cross-linking
Related Content
4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform
December 20th 2024

4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Iantrek, Inc. announces 1-Year outcomes from the CREST Registry for bio-interventional glaucoma treatment
December 13th 2024

Iantrek, Inc. announces 1-Year outcomes from the CREST Registry for bio-interventional glaucoma treatment

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Generative AI: It’s only just begun
December 9th 2024

Generative AI: It’s only just begun

Study highlights current and potential roles of AI in glaucoma diagnosis
December 7th 2024

Study highlights current and potential roles of AI in glaucoma diagnosis

© 2024 MJH Life Sciences

All rights reserved.